|
Re: This is Great
|
3
|
Resverlogix Corp.
|
Nov 08, 2023 12:44PM
|
|
From the This Is Great string on the RVX board
|
2
|
Zenith Epigenetics
|
Nov 08, 2023 12:08AM
|
|
Re: This is Great
|
4
|
Resverlogix Corp.
|
Nov 07, 2023 10:17PM
|
|
Re: This is Great
|
3
|
Resverlogix Corp.
|
Nov 07, 2023 03:22PM
|
|
Re: Notice anything different about #11
|
|
Zenith Epigenetics
|
Oct 26, 2023 08:14PM
|
|
Re: This so called “Expert Market”
|
3
|
Zenith Epigenetics
|
Oct 26, 2023 12:44PM
|
|
Notice anything different about #11
|
|
Zenith Epigenetics
|
Oct 26, 2023 12:13AM
|
|
Re: Recent publications:
|
3
|
Resverlogix Corp.
|
Sep 27, 2023 03:28PM
|
|
Re: wideout,Tada etc…
|
2
|
Resverlogix Corp.
|
Sep 14, 2023 12:45PM
|
|
Re: Morocco
|
3
|
Resverlogix Corp.
|
Sep 12, 2023 05:13PM
|
|
Re: Rumour has it
|
3
|
Resverlogix Corp.
|
Sep 11, 2023 03:04PM
|
|
Re: Rumour has it
|
5
|
Resverlogix Corp.
|
Sep 11, 2023 12:57PM
|
|
Re: Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes
|
6
|
Resverlogix Corp.
|
Aug 29, 2023 01:39PM
|
|
Re: I believe the big/long wait
|
2
|
Resverlogix Corp.
|
Aug 25, 2023 12:28PM
|
|
Re: Financial Statement Q2, 2023 /MD&A
|
2
|
Resverlogix Corp.
|
Aug 13, 2023 05:07PM
|
|
Re: New SEDAR page
|
|
Zenith Epigenetics
|
Aug 10, 2023 12:55PM
|
|
Re: Additional Reports of Exempt Distribution
|
3
|
Zenith Epigenetics
|
Jul 25, 2023 02:48AM
|
|
Re: For what it’s worth
|
2
|
Zenith Epigenetics
|
Jul 19, 2023 05:13PM
|
|
Re: For what it’s worth
|
2
|
Zenith Epigenetics
|
Jul 19, 2023 05:11PM
|
|
Re: Trodelvy - development history and valuations along the way
|
|
Zenith Epigenetics
|
Jul 04, 2023 02:35PM
|
